Briefly, what anesthetic technique should be used for a given procedure?

Ubrelvy and Anesthesia

Ubrelvy (ubrogepant) does not require specific anesthetic technique modifications and can be safely continued perioperatively, though the choice of anesthetic technique should be guided by the surgical procedure itself rather than this medication.

Key Considerations

Ubrelvy is a CGRP receptor antagonist used for acute migraine treatment. There are no documented interactions between ubrogepant and anesthetic agents that would necessitate changes to standard anesthetic protocols. The medication does not affect:

• Airway management
• Hemodynamic stability during anesthesia
• Neuromuscular blockade
• Anesthetic depth requirements

Anesthetic Technique Selection

The anesthetic technique should be determined by the surgical procedure, patient comorbidities, and clinical context—not by Ubrelvy use. The evidence strongly supports procedure-specific approaches:

For Regional Anesthesia Candidates

Prioritize regional anesthesia whenever feasible 1. Regional techniques offer:

• Reduced exposure to general anesthetic agents
• Better postoperative pain control
• Faster recovery
• Lower risk of postoperative complications

This is particularly relevant for:

• Orthopedic procedures (neuraxial or peripheral nerve blocks) 2, 3
• Abdominal surgeries (fascial plane blocks, epidural) 4
• Thoracic procedures (paravertebral, fascial plane blocks) 4
• Obstetric procedures (neuraxial techniques preferred) 5

For General Anesthesia

When general anesthesia is required, use short-acting agents with multimodal analgesia 6:

• Induction: Propofol with short-acting opioids (fentanyl, remifentanil)
• Maintenance: Sevoflurane or desflurane in oxygen-enriched air, or total intravenous anesthesia (TIVA)
• Muscle relaxation: Short-acting agents with neuromuscular monitoring
• Avoid deep anesthesia: Use BIS monitoring in elderly patients to prevent excessive depth 6

Multimodal Analgesia Framework

Regardless of primary anesthetic technique, implement opioid-sparing multimodal analgesia:

1. Non-opioid baseline: Paracetamol + NSAID or COX-2 inhibitor 6, 2, 3
2. Regional technique: When appropriate for the procedure
3. Opioids: Reserve for breakthrough pain only

Perioperative Management of Ubrelvy

• Continue through surgery: No need to hold Ubrelvy perioperatively
• No drug interactions: Standard anesthetic agents (propofol, volatile anesthetics, opioids, neuromuscular blockers) have no known interactions with ubrogepant
• Postoperative resumption: Can be restarted immediately when oral intake resumes

Common Pitfalls to Avoid

• Do not modify standard airway management for Ubrelvy patients
• Do not avoid regional techniques due to Ubrelvy use—there are no contraindications
• Do not assume general anesthesia is required; assess procedure-specific needs first 1
• Do not use deep anesthesia unnecessarily, particularly in elderly patients 6

Clinical Algorithm

1. Assess the surgical procedure → Determine if regional anesthesia is feasible
2. If regional is appropriate → Proceed with neuraxial or peripheral nerve block
3. If general anesthesia required → Use balanced technique with short-acting agents
4. Always add → Multimodal non-opioid analgesia (paracetamol + NSAID)
5. Continue Ubrelvy → No perioperative interruption needed

The presence of Ubrelvy in a patient's medication regimen should not influence anesthetic decision-making. Focus instead on procedure-specific requirements, patient comorbidities, and evidence-based regional anesthesia techniques when applicable 1, 6, 4.